Garlapati Jay K, Howard Desten, Maier Jordan, Joiner Michael C, Miller Steven R
Department of Oncology, Wayne State University School of Medicine, Detroit, USA.
Department of Pathology, Wayne State University School of Medicine, Detroit, USA.
Cureus. 2025 Apr 4;17(4):e81710. doi: 10.7759/cureus.81710. eCollection 2025 Apr.
Primary small cell carcinoma of the breast (PSCCB) is a rare but aggressive disease with multiple treatment options available, including surgery, chemotherapy, and radiation therapy. We report a case of a 51-year-old female patient who presented with a palpable left breast mass. An ultrasound-guided core needle biopsy of the affected area revealed triple-negative small cell carcinoma of the left breast. The patient underwent neoadjuvant chemotherapy, breast-conserving surgery with negative margins, and post-operative radiation therapy. One year later, the patient developed pathologic evidence of metastatic disease. Despite receiving three additional chemotherapeutic regimens and site-specific radiation treatments, the patient continued to have widespread metastatic disease. This case underscores the challenges of diagnosing and treating PSCCB and the urgent need for creating a standardized treatment protocol to improve patient outcomes.
原发性乳腺小细胞癌(PSCCB)是一种罕见但侵袭性强的疾病,有多种治疗选择,包括手术、化疗和放疗。我们报告一例51岁女性患者,其左乳可触及肿块。对患区进行超声引导下的粗针活检,结果显示为左乳三阴性小细胞癌。该患者接受了新辅助化疗、切缘阴性的保乳手术及术后放疗。一年后,患者出现了转移疾病的病理证据。尽管又接受了三种化疗方案和针对特定部位的放疗,但患者仍有广泛的转移疾病。该病例凸显了诊断和治疗PSCCB的挑战,以及迫切需要制定标准化治疗方案以改善患者预后。